Pfizer Inc. (PFE)
27.80
-0.32
(-1.14%)
USD |
NYSE |
Oct 02, 16:00
27.80
0.00 (0.00%)
After-Hours: 20:00
Pfizer Max Drawdown (5Y) : 58.95% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 58.95% |
| August 31, 2026 | 58.95% |
| July 31, 2026 | 58.95% |
| June 30, 2026 | 58.95% |
| May 31, 2026 | 58.95% |
| April 30, 2026 | 58.95% |
| March 31, 2026 | 58.95% |
| February 28, 2026 | 58.95% |
| January 31, 2026 | 58.95% |
| December 31, 2025 | 58.95% |
| November 30, 2025 | 58.95% |
| October 31, 2025 | 58.95% |
| September 30, 2025 | 58.95% |
| August 31, 2025 | 58.95% |
| July 31, 2025 | 58.95% |
| June 30, 2025 | 58.95% |
| May 31, 2025 | 58.95% |
| April 30, 2025 | 58.95% |
| March 31, 2025 | 54.78% |
| February 28, 2025 | 54.78% |
| January 31, 2025 | 54.78% |
| December 31, 2024 | 54.78% |
| November 30, 2024 | 54.78% |
| October 31, 2024 | 54.78% |
| September 30, 2024 | 54.78% |
| Date | Value |
|---|---|
| August 31, 2024 | 54.78% |
| July 31, 2024 | 54.78% |
| June 30, 2024 | 54.78% |
| May 31, 2024 | 54.78% |
| April 30, 2024 | 54.78% |
| March 31, 2024 | 53.93% |
| February 29, 2024 | 53.93% |
| January 31, 2024 | 53.93% |
| December 31, 2023 | 53.93% |
| November 30, 2023 | 48.91% |
| October 31, 2023 | 47.64% |
| September 30, 2023 | 44.19% |
| August 31, 2023 | 39.13% |
| July 31, 2023 | 38.90% |
| June 30, 2023 | 37.89% |
| May 31, 2023 | 37.27% |
| April 30, 2023 | 35.44% |
| March 31, 2023 | 35.44% |
| February 28, 2023 | 35.44% |
| January 31, 2023 | 35.44% |
| December 31, 2022 | 35.44% |
| November 30, 2022 | 35.44% |
| October 31, 2022 | 35.44% |
| September 30, 2022 | 35.44% |
| August 31, 2022 | 35.44% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Johnson & Johnson | 18.44% |
| Eli Lilly & Co. | 34.47% |
| Merck & Co., Inc. | 43.45% |
| Bristol Myers Squibb Co. | 47.67% |
| Viatris, Inc. | 81.23% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -9.850 |
| Beta (5Y) | 0.3198 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 24.50% |
| Historical Sharpe Ratio (5Y) | -0.2715 |
| Historical Sortino (5Y) | -0.5264 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 10.34% |